Verkkokauppa.com Oyj - Managers' Transactions – Seppälä
May 06, 2024 06:15 ET
|
Verkkokauppa.com Oyj
Verkkokauppa.com Oyj - Managers' Transactions – Seppälä Verkkokauppa.com Oyj MANAGERS’ TRANSACTIONS 6 May 2024 at 1:15 p.m. EEST Verkkokauppa.com Oyj has received a notification from...
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 06, 2024 06:10 ET
|
ADC Therapeutics SA
ZYNLONTA® (loncastuximab tesirine-lpyl) net sales of $17.8 million in 1Q 2024; total operating expenses decreased 25% (adjusted total operating expenses decreased 16%)1 compared to 1Q 2023 ...
MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
May 06, 2024 06:05 ET
|
MannKind
MANNKIND RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR CLOFAZIMINE INHALATION SUSPENSION FOR THE TREATMENT OF SERIOUS LUNG DISEASE
CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE AVRIL 2024
May 06, 2024 06:02 ET
|
CREDIT AGRICOLE SA
Raison sociale de l’émetteur : Crédit Agricole S.A. – SA au capital de 9 077 707 050 eurosImmatriculée sous le n° 784 608 416 R.C.S. NANTERRESiège social : MONTROUGE (92120) 12, place des Etats-Unis ...
ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
May 06, 2024 06:00 ET
|
ADC Therapeutics SA
Initial data from 15 patients with relapsed/refractory (r/r) marginal zone lymphoma (MZL) show 13 patients achieved a complete response and one patient achieved a partial response with ZYNLONTA® All...
Veterinary Scales Market to Reach $0.52 Billion by 2033; Rapidly Growing Pet Population to Propel Growth
May 06, 2024 06:00 ET
|
The Brainy Insights
Newark, May 06, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 0.25 Billion Veterinary Scales Market will reach USD 0.52 Billion by 2033. Technological penetration in the global...
USI Insurance Services Acquires Hignojos Insurance Agency
May 06, 2024 06:00 ET
|
USI Insurance Services
VALHALLA, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- USI Insurance Services (“USI”), a world leader in risk management, employee benefit and retirement plan consulting, today announced the acquisition...
Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
May 06, 2024 06:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health...
AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)
May 06, 2024 06:00 ET
|
Asclepix
The DISCOVER Phase 1/2a trial is an open-label, single ascending dose, 9-month study that will evaluate the safety and bioactivity of AXT107 (gersizangitide) injected suprachoroidally in patients with...
Pulsar Helium Announces Spring Road Restrictions End at Topaz Project
May 06, 2024 06:00 ET
|
Pulsar Helium
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Pulsar Helium Inc. (TSXV:PLSR & OTCQB:PSRHF) (“Pulsar” or the “Company”) is pleased to announce that the Minnesota Department of...